Desq Long
Sign in
SEC FORM 4
$1,351.42

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Disposition (code F) of 343 shares at $3.94 per share.

Reporting Person Elmelech Idan · Officer Title COO & Principal Financial Ofcr · Transaction Code F

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001193125-26-414131 · filed 2026-10-05 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "BridgeBio Oncology Therapeutics, Inc. (BBOT)." Disclosed 2026-10-05. https://desqlong.com/cards/0001193125-26-414131-1 (retrieved 2026-10-06).